5篇
您的检索式：作者名="Amit Tevar"
|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Laparoscopic Cholecystectomy in the Cirrhotic Patient: Predictors of Outcome显示文摘 | Ralph C. Quillin Justin M. Burns Jaime A. Pineda Dennis Hanseman Steven M. Rudich Michael J. Edwards Amit D. Tevar | 2012 | Surgery2012，，： | 2 |
| 2 | Bortezomib Provides Effective Therapy for Antibody- and Cell-Mediated Acute Rejection显示文摘 | Matthew J. Everly Jason J. Everly Brian Susskind Paul Brailey Lois J. Arend Rita R. Alloway Prabir Roy-Chaudhury Amit Govil Gautham Mogilishetty Adele H. Rike Michael Cardi George Wadih Amit Tevar E Steve Woodle | 2008 | Transplantation2008，，12： | 2 |
| 3 | Portal vein ligation accelerates tumor growth in ligated,but not contralateral lobes显示文摘AIM: To investigate the mechanisms of liver growth and atrophy after portal vein ligation (PVL) and its effects on tumor growth. METHODS: Mice were subjected to PVL, partial hepatectomy, or sham surgery. The morphological alterations, activation of transcription factors, and expression of cytokines and growth factors involved in liver regeneration were evaluated. In a separate set of experiments, murine colorectal carcinoma cells were injected via the portal vein and the effect of each operation on liver tumor growth was studied. RESULTS: Liver regeneration after PVL and partial hepatectomy were very similar. In ligated lobes, various cytokines, transcription factors and regulatory factors were signifi cantly upregulated compared to nonligated lobes after PVL. Atrophy in ligated lobes was a result of early necrosis followed by later apoptosis. Tumor growth was signifi cantly accelerated in ligated compared to non-ligated lobes.CONCLUSION: Tumor growth was accelerated in ligated liver lobes and appeared to be a result of increased growth factor expression. | Nozomu Sakai Callisia N Clarke Rebecca Schuster John Blanchard Amit D Tevar Michael J Edwards Alex B Lentsch | 2010 | World Journal of Gastroenterology2010，16，30： | 1 |
| 4 | De Novo Cancers Arising in Organ Transplant Recipients are Associated With Adverse Outcomes Compared With the General Population显示文摘 | Yun Miao Jason J. Everly Thomas G. Gross Amit D. Tevar M Roy First Rita R. Alloway E Steve Woodle | 2009 | Transplantation2009，，9： | 1 |
| 5 | Liver retransplants using living donors:An approach for management显示文摘Background and aims:Many centers do not offer living donor transplants for patients in need of a liver retransplant.We aimed to study our liver retransplant outcomes using living donors and compared them with those of retransplants performed using deceased donors.Methods:This study retrospectively analyzed all retransplants performed at our center between 2009 and 2023,and outcomes of living donor retransplants were compared with deceased donor retransplants using standard statistical tests.Results:Between January 2009 and March 2023,a total of 77 retransplants,60 with deceased donors and 17 with living donors,were performed.Important demographic differences between the two groups included a higher model for end-stage liver disease score in the deceased donor group(32.1±6.1 vs.19.4±5.7,P<0.001)and a higher number of early retransplants(within 3 months of the initial transplant),which accounted for 35% of deceased donor transplants but 0 of living donor transplants(P<0.01).Overall,the patient and graft survival rates were comparable between the two groups.The patient survival rates at 1 and 3 years after transplant were 73% and 67% in the deceased donor group and 84% and 73% in the living donor group,respectively(P=0.57).The hospital length of stay and blood product use were both better in the living donor group.Biliary complications did not show significant different between the two groups(P=0.33).Conclusions:Living donors can provide acceptable outcomes for those in need of a retransplant,with results comparable to those seen with deceased donors.A systematic approach to the patient in the pre-,peri-,and post-transplantation period is important in these complicated cases. | Hasan Al Harakeh Christopher Hughes Amit Tevar Vikram Gunabushanam Eishan Ashwat Hao Liu Abhinav Humar | 2023 | Liver Research2023，7，3： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员